Pharmaceutical compositions comprising therapeutically effective amounts of R(+) and S(-) pramipexole, multicomponent pharmaceutical compositions of the same, and therapeutically effective amounts of R (+) and S(-) pramipexole for use in the treatment or prevention of Parkinsons disease or the symptoms thereof are provided.